{"gene":"HOXA3","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1995,"finding":"Targeted disruption of Hoxa3 results in athymia and thyroid hypoplasia; analysis with carbocyanine dye and molecular markers showed neural crest migration was not grossly affected, indicating Hoxa3 affects the intrinsic capacity of neural crest cells to differentiate and/or induce proper differentiation of surrounding pharyngeal tissues. Hoxa3 loss causes a marked reduction in Pax1 expression in neural crest cells of the 3rd pharyngeal pouch, suggesting Hoxa3 is required to maintain Pax1 expression as part of the athymic phenotype.","method":"Gene targeting (knockout mouse), carbocyanine dye injection, molecular marker analysis, in situ hybridization","journal":"Development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — loss-of-function mouse model with multiple orthogonal methods (dye tracing, molecular markers, in situ hybridization), replicated in subsequent studies","pmids":["7635047"],"is_preprint":false},{"year":1994,"finding":"Hoxa3 and Hoxd3 show synergistic, dosage-dependent interactions: double mutants show deletion of the entire atlas rather than simple homeotic transformation seen in single Hoxd3 mutants, interpreted as differential regulation of proliferation rates of precursor cells.","method":"Genetic epistasis (double knockout mice), skeletal analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with double mutants clearly establishing synergistic interaction, published in high-impact journal with rigorous controls","pmids":["7913519"],"is_preprint":false},{"year":1999,"finding":"Hoxa3 expression in rhombomeres 5 and 6 of the hindbrain is directly regulated by the Maf bZIP transcription factor Krml1 (kreisler): a single high-affinity Krml1 binding site in a 600 bp enhancer in the Hoxa3/Hoxa4 intergenic region is necessary and sufficient for r5/r6 expression, and this activity depends on endogenous kreisler.","method":"Transgenic enhancer analysis, deletion mapping, electrophoretic mobility shift assay (binding site identification), ectopic kreisler expression, kreisler mutant analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (transgenic analysis, binding site mutagenesis, genetic loss-of-function), replicated with kreisler mutant embryos","pmids":["9895323"],"is_preprint":false},{"year":2001,"finding":"Hoxa3 and Pax1 act synergistically in a genetic pathway required for thymic epithelial cell development: Hoxa3(+/-)Pax1(-/-) compound mutants show defective MHC class II+ epithelial cells, reduced thymocyte maturation with a block at CD4-8- to CD4+8+ transition, and increased apoptosis of CD4+8+ thymocytes. Fetal liver adoptive transfer showed the defect resides in radio-resistant stromal (epithelial) cells, not hematopoietic cells.","method":"Compound mutant mice (genetic epistasis), fetal liver adoptive transfer, flow cytometry, immunohistochemistry","journal":"Journal of Immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with compound mutants, cell-type specificity established by adoptive transfer, multiple orthogonal readouts","pmids":["10820253"],"is_preprint":false},{"year":2001,"finding":"Maintenance of Hoxa3 expression in r5 and r6 during late hindbrain development is controlled by a conserved cis-element containing two bipartite Hox/Pbx-binding sites that mediate auto- and cross-regulatory feedback loops, independently of kreisler. This element is conserved in human and horn shark Hoxa3 loci.","method":"Transgenic analysis in mouse and chick embryos, deletion analysis of cis-regulatory elements, site-directed mutagenesis of Hox/Pbx binding sites","journal":"Development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — regulatory element characterized by transgenic analysis, mutagenesis of binding sites, cross-species conservation, and in vivo functional validation","pmids":["11566863"],"is_preprint":false},{"year":2001,"finding":"Hoxa3 and Pax1 regulate epithelial cell death and proliferation during thymus and parathyroid organogenesis: compound mutants show increased apoptosis in the forming primordium, and Gcm2 (parathyroid marker) expression is progressively lost while thymus-specific Foxn1 initiates normally but thymic epithelial cells die. The Hoxa3-Pax1 pathway is required for both epithelial cell growth and differentiation.","method":"Compound mutant mice, immunohistochemistry, in situ hybridization for organ-specific markers (Gcm2, Foxn1), apoptosis assays","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — compound mutant genetic pathway analysis with specific molecular marker readouts, replicated across multiple studies","pmids":["11476574"],"is_preprint":false},{"year":2002,"finding":"Hoxa3 is essential for formation of the carotid body; in null mutants, the third arch artery degenerates bilaterally beginning at E10.5, leading to malformation of the carotid artery system and absence of carotid body. Neural crest cell migration to the third arch was not affected.","method":"Knockout mouse analysis, histology, immunohistochemistry","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — complete penetrance (10/10 mutants) loss-of-function with defined cellular mechanism (third arch artery degeneration), replicated in subsequent studies","pmids":["12074562"],"is_preprint":false},{"year":2003,"finding":"Targeted overexpression of Hoxa3 in the rostral hindbrain (r1-4) leads to generation of ectopic somatic motoneurones and repression of the dorsoventral patterning gene Irx3, demonstrating Hoxa3 is sufficient to specify somatic motoneurone identity and acts upstream of Irx3.","method":"Heterotopic rhombomere transplantation, targeted overexpression (gain-of-function), in situ hybridization for Irx3","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with molecular readout (Irx3 repression), single study","pmids":["12756180"],"is_preprint":false},{"year":2004,"finding":"Hoxa3 null mutation prevents differentiation of the third pharyngeal pouch into the parathyroid rudiment (absence of SP-1/chromogranin A immunoreactivity at E11.5), while neural crest cell migration to surround the third pouch epithelium is unaffected, indicating Hoxa3 acts cell-autonomously in pouch endoderm for parathyroid initiation.","method":"Knockout mouse, immunohistochemistry (SP-1/chromogranin A), connexin43-lacZ transgene for neural crest cell visualization","journal":"Journal of Histochemistry and Cytochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with specific molecular marker and cell-lineage tracing, single lab","pmids":["15100241"],"is_preprint":false},{"year":2005,"finding":"HOXA3 promotes endothelial cell migration and angiogenesis in vivo, and increases expression of MMP-14 and uPAR genes in endothelial cells in culture and in vivo during wound healing. HOXA3-induced migration of endothelial cells and keratinocytes is uPAR-dependent. Gene transfer of HOXA3 into diabetic mouse wounds improves angiogenesis and wound closure.","method":"Gene transfer (in vivo), endothelial cell migration assay, angiogenesis assay in vivo, gene expression analysis (MMP-14, uPAR), uPAR blocking experiments","journal":"Journal of Cell Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (in vitro migration assay, in vivo gene transfer, pathway blocking with uPAR), replicated in subsequent studies","pmids":["15914537"],"is_preprint":false},{"year":2005,"finding":"Hoxa3 is required for proliferation and differentiation of the third pharyngeal arch mesenchyme: null mutants show delayed fusion of the third pharyngeal arch with the second and fourth arches, reduced number of proliferating cells in the third arch, and regression of the third arch artery at E11.5. Neural crest cell migration to the third arch is not affected.","method":"Knockout mouse with connexin43-lacZ neural crest reporter, BrdU proliferation assay, whole-mount X-gal staining, immunohistochemistry","journal":"Cell and Tissue Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with cell-lineage tracing and proliferation assay, single lab","pmids":["15714286"],"is_preprint":false},{"year":2009,"finding":"HOXA3 expression in diabetic mouse wounds significantly increases mobilization and recruitment of endothelial progenitor cells (bone marrow-derived) while reducing inflammatory cell recruitment. HOXA3 locally suppresses expression of pro-inflammatory NF-κB pathway members (MyD88, TOLLIP) as identified by microarray.","method":"GFP bone marrow chimeras, gene transfer (in vivo), flow cytometry, microarray gene expression analysis","journal":"Stem Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo cell-tracking with BM chimeras and gene expression profiling, single lab","pmids":["19544454"],"is_preprint":false},{"year":2010,"finding":"HoxA3 restrains haematopoietic differentiation of hemogenic endothelium by downregulating key haematopoietic transcription factors including Runx1, Gata1, Gfi1B, Ikaros, and PU.1. Loss-of-function and gain-of-function epistasis experiments showed that Runx1 is uniquely able to erase the endothelial program set up by HoxA3, establishing HoxA3 as an apical regulator of the endothelial-to-hematopoietic transition.","method":"Loss-of-function and gain-of-function experiments, epistasis analysis, gene expression profiling, cell fate assays (CD41 marker)","journal":"Nature Cell Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal loss- and gain-of-function with epistasis, multiple target transcription factors identified, published in high-impact journal","pmids":["21170035"],"is_preprint":false},{"year":2010,"finding":"Hoxa3 promotes differentiation of hematopoietic progenitor cells into proangiogenic Gr-1+CD11b+ myeloid cells; sustained Hoxa3 expression in diabetic-derived Gr-1+CD11b+ cells reverses their diabetic phenotype (restoring proliferation, chemotaxis, adhesion, and differentiation) and stimulates neovascularization in vivo.","method":"Gene transfer (ex vivo and in vivo), flow cytometry, proliferation/chemotaxis/adhesion assays, in vivo angiogenesis assay","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional rescue experiments in primary cells with in vivo validation, single lab","pmids":["20974673"],"is_preprint":false},{"year":2010,"finding":"Mouse and zebrafish Hoxa3a proteins have nonequivalent in vivo function: zebrafish hoxa3a expressed from the mouse Hoxa3 locus can substitute for mouse Hoxa3 in some tissues but not others, and the functional difference maps primarily to the C-terminal domain of the protein, as shown by a chimeric protein allele.","method":"Knock-in mouse (zebrafish hoxa3a expressed from mouse locus), chimeric protein allele, tissue-specific phenotypic rescue analysis","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — chimeric protein allele directly maps functional divergence to C-terminal domain, multiple tissue readouts in vivo","pmids":["20498049"],"is_preprint":false},{"year":2014,"finding":"Tissue-specific deletion experiments show Hoxa3 has distinct cell-autonomous roles: in endoderm, it temporally regulates initiation of the thymus program and is required cell-autonomously for parathyroid differentiation; in neural crest cells, it is primarily required for morphogenesis (organ migration). Expression in either tissue alone is sufficient for organ survival, while simultaneous deletion in both endoderm and NCC leads to athymia similar to the null.","method":"Tissue-specific conditional knockout (endoderm-Cre, NCC-Cre, double Cre), lineage analysis with Hoxa3-Cre, marker expression analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple tissue-specific Cre knockouts with clear cell-autonomous vs non-autonomous distinctions, supported by lineage tracing","pmids":["25249461"],"is_preprint":false},{"year":2016,"finding":"Hoxa3 protein transduction in macrophages enhances macrophage maturation, inhibits M1 (classical) polarization, and promotes M2 (alternative) polarization, in part via regulation of Pu.1/Spi1 and Stat6. In vivo, sustained Hoxa3 expression reduces Nos2+ (M1-like) macrophages and increases Arg1+/VEGF+ (M2-like) macrophages in diabetic wounds. This phenotypic switching occurs in a DNA-binding independent manner.","method":"Protein transduction in vitro, in vivo gene transfer, flow cytometry, Western blot (Pu.1, Stat6), immunofluorescence (Nos2, Arg1, VEGF)","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo protein transduction with mechanistic pathway readouts (Pu.1, Stat6), single lab","pmids":["27342843"],"is_preprint":false},{"year":2016,"finding":"Comprehensive temporal/spatial analysis shows HOXA3 functions in both cell-autonomous and non-cell-autonomous manners: cell-autonomously in tracheal epithelium, thymus, and parathyroid endodermal cells for differentiation; non-cell-autonomously in NCCs for structures that are Hoxa3-lineage-negative. These defects reflect roles in differentiation and morphogenesis programs rather than positional identity.","method":"Temporal conditional knockout (tamoxifen-inducible Cre), tissue-specific Cre, Hoxa3-Cre lineage tracing, marker expression analysis","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — comprehensive conditional knockout series with lineage tracing providing clear cell-autonomous vs non-autonomous distinctions across multiple structures","pmids":["27178667"],"is_preprint":false},{"year":2017,"finding":"HoxA3 inhibits the Notch pathway in hemogenic endothelium by inducing upregulation of the Jagged1 (Jag1) ligand, which causes cis-inhibition of Notch signaling, rendering hemogenic endothelial cells non-responsive to Notch signals. Notch activation or Jag1 downregulation is required to downregulate endothelial markers as a prerequisite for endothelial-to-hematopoietic transition (EHT).","method":"Gain-of-function (HoxA3 overexpression), Notch pathway activation/inhibition, Jag1 knockdown, gene expression analysis, cell phenotype assays","journal":"PLoS One","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic dissection of HoxA3-Notch-Jag1 axis with multiple interventions, single lab building on prior work","pmids":["29073173"],"is_preprint":false},{"year":2019,"finding":"Diabetic-derived human macrophages show maturation defects associated with reduced RUNX1 expression. Protein transduction of Hoxa3 rescues inflammation and maturation defects in diabetic human macrophages via upregulation of Runx1, and also modulates p65/NF-κB levels, histone acetyltransferase/deacetylase activity, and inhibits acetylation of the TNF promoter.","method":"Protein transduction, Western blot (RUNX1, p65/NF-κB), histone acetyltransferase/deacetylase activity assay, chromatin immunoprecipitation (TNF promoter acetylation), flow cytometry","journal":"PLoS One","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal mechanistic readouts in primary human cells, single lab","pmids":["31626638"],"is_preprint":false},{"year":2020,"finding":"GDF11 promotes HOXA3 expression via Smad2/3 pathway activation, and HOXA3 negatively regulates NLRP3 inflammasome expression; HOXA3 was confirmed as a transcriptional regulator of NLRP3 by ChIP assay, forming a GDF11/Smad2/3/HOXA3/NLRP3 signaling pathway that inhibits cardiomyocyte pyroptosis.","method":"ChIP assay, AAV9-mediated gene overexpression in vivo, Western blot (Smad2/3 pathway), gene knockdown/overexpression","journal":"Cell Death & Disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP assay establishes direct HOXA3-NLRP3 transcriptional regulation, in vivo validation, single lab","pmids":["33100331"],"is_preprint":false},{"year":2021,"finding":"HOXA3 negatively regulates transcription of the HO-1 (heme oxygenase-1) gene; PRRSV induces HOXA3 upregulation, which suppresses HO-1 transcription, thereby weakening HO-1-IRF3 interaction, reducing IRF3 phosphorylation and nuclear translocation, and suppressing type I interferon (IFN-β and ISG) production.","method":"Luciferase reporter assay (HO-1 promoter), gene knockdown/overexpression, co-immunoprecipitation (HO-1-IRF3), Western blot (IRF3 phosphorylation, nuclear translocation), viral infection assay","journal":"Journal of Virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (reporter assay, Co-IP, phosphorylation analysis) establishing mechanistic pathway, single lab","pmids":["34851144"],"is_preprint":false},{"year":2021,"finding":"The Hoxa3 5'UTR contains an upstream ORF (uORF) that is critical for inhibiting cap-dependent translation of Hoxa3 mRNA, forming a Translation Inhibitory Element (TIE). The non-canonical initiation factor eIF2D is required for this uORF-mediated cap-dependent translation inhibition, while an IRES in the same 5'UTR enables cap-independent translation.","method":"In vitro translation assay, uORF mutagenesis, eIF2D requirement experiments, reporter assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis of the uORF and identification of specific initiation factor (eIF2D), single lab but multiple orthogonal biochemical methods","pmids":["34076576"],"is_preprint":false},{"year":2021,"finding":"HOXA2 and HOXA3 can heterodimerise, which may have functional consequences for HOX patterning in vivo. In vitro binding characterization showed that the highest enriched motif in HOXA2 chromatin peaks is not recognized by HOXA2 in vitro, highlighting the importance of in vivo context for HOX binding specificity.","method":"ChIP-seq (in vivo binding), in vitro binding assay (EMSA or equivalent), protein-protein interaction assay for heterodimerization","journal":"Journal of Developmental Biology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — heterodimerization shown by single method in single study; functional consequences not directly tested","pmids":["34940502"],"is_preprint":false},{"year":2024,"finding":"HOXA3 transcriptionally activates USP15 expression (confirmed by ChIP, EMSA, and dual-luciferase reporter assays), and USP15 then deubiquitinates SQSTM1. This HOXA3/USP15/SQSTM1 axis suppresses autophagy (inhibiting autolysosome fusion) and promotes M2-type macrophage polarization in renal cell carcinoma through stimulation of CCL2 secretion.","method":"ChIP assay, EMSA, dual-luciferase reporter assay, Co-immunoprecipitation (USP15-SQSTM1 interaction), ubiquitination assay, immunofluorescence (LC3/LAMP2), in vivo xenograft experiment, Western blot","journal":"American Journal of Physiology Cell Physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (ChIP, EMSA, luciferase, Co-IP, ubiquitination assay) in single lab establishing transcriptional and post-translational mechanism","pmids":["39740793"],"is_preprint":false},{"year":2024,"finding":"HOXA3 regulates the differentiation, proliferation, and migration of third pharyngeal pouch endoderm (3PPE) derived from hESCs, and controls 3PPE commitment through the Wnt signaling pathway by transcriptionally activating EPHB2.","method":"hESC differentiation, HOXA3 knockdown, gene expression analysis, Wnt pathway reporter/assay, cell proliferation and migration assays","journal":"Frontiers in Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional knockdown with defined molecular pathway (EPHB2/Wnt), in vitro hESC model, single lab","pmids":["38259452"],"is_preprint":false},{"year":2024,"finding":"Short WT1 transcripts (sWT1+/-) specifically upregulate HOXA3, and overexpression of HOXA3 alone reproduces the effects of sWT1+/- in AML cells: decreased cell growth, G1 arrest, reduced CD71 expression, and cytarabine resistance, demonstrating HOXA3 as a downstream effector of isoform-specific WT1 in mediating chemotherapy resistance.","method":"RNA-seq differential expression, HOXA3 overexpression, flow cytometry (cell cycle, CD71), cytarabine resistance assay","journal":"British Journal of Haematology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — overexpression rescue experiment establishing HOXA3 as downstream effector, molecular pathway placement, single lab","pmids":["38867543"],"is_preprint":false}],"current_model":"HOXA3 is a homeodomain transcription factor that acts through direct DNA binding (at Hox/Pbx bipartite sites and target gene promoters) to control cell fate decisions in pharyngeal organ development (thymus, parathyroid, carotid body) by regulating Pax1, Gcm2, and Foxn1 expression in third pharyngeal pouch endoderm and neural crest cells; it additionally functions as an apical regulator of the endothelial-to-hematopoietic transition by suppressing Runx1 and inducing Jag1-mediated Notch cis-inhibition, promotes wound healing and angiogenesis by inducing MMP-14 and uPAR expression in a uPAR-dependent manner, modulates macrophage M1/M2 polarization via Pu.1/Spi1, Stat6, and NF-κB pathways, transcriptionally activates USP15 (leading to SQSTM1 deubiquitination and autophagy suppression), and its own translation is controlled by a 5'UTR uORF-based Translation Inhibitory Element (TIE) requiring eIF2D, while early hindbrain expression is initiated by kreisler/Krml1 binding and maintained by auto/cross-regulatory Hox/Pbx feedback loops."},"narrative":{"mechanistic_narrative":"HOXA3 is a homeodomain transcription factor that controls cell-fate decisions during pharyngeal organ development and hematovascular differentiation by directly regulating downstream target genes [PMID:7635047, PMID:21170035, PMID:39740793]. In the third pharyngeal pouch it acts cell-autonomously in endoderm to initiate the thymus program and to drive parathyroid differentiation, and non-cell-autonomously in neural crest cells for organ morphogenesis, with combined loss in both lineages reproducing the null athymic phenotype [PMID:25249461, PMID:27178667]; mechanistically it maintains Pax1 expression and operates in a Hoxa3–Pax1 genetic pathway governing epithelial proliferation, survival, and differentiation marked by Gcm2 and Foxn1 [PMID:7635047, PMID:10820253, PMID:11476574], and is required for carotid body formation through maintenance of the third arch artery [PMID:12074562]. Its early hindbrain expression in rhombomeres 5/6 is initiated by direct binding of the Maf factor Krml1 (kreisler) to a single high-affinity enhancer site and subsequently maintained through auto- and cross-regulatory Hox/Pbx feedback loops [PMID:9895323, PMID:11566863]. HOXA3 is an apical regulator of the endothelial-to-hematopoietic transition, restraining hematopoietic commitment by downregulating Runx1 and other key hematopoietic transcription factors and by inducing Jagged1-mediated cis-inhibition of Notch signaling [PMID:21170035, PMID:29073173]. In wound healing it promotes endothelial migration and angiogenesis through uPAR-dependent induction of MMP-14 and uPAR, mobilizes endothelial progenitor cells, and steers myeloid cells toward proangiogenic, M2-polarized states via Pu.1/Spi1, Stat6, Runx1, and NF-κB modulation [PMID:15914537, PMID:19544454, PMID:20974673, PMID:27342843, PMID:31626638]. HOXA3 additionally functions as a direct transcriptional regulator in disease contexts, activating USP15 to suppress autophagy via SQSTM1 deubiquitination [PMID:39740793] and repressing NLRP3 and HO-1 to modulate inflammasome and interferon responses [PMID:33100331, PMID:34851144]. Its own expression is post-transcriptionally constrained by a 5'UTR uORF-based Translation Inhibitory Element that requires the non-canonical factor eIF2D for cap-dependent inhibition [PMID:34076576].","teleology":[{"year":1994,"claim":"Established that Hoxa3 acts in dosage-dependent synergy with Hoxd3 to control axial skeletal precursor cell behavior rather than acting alone in simple positional identity.","evidence":"Genetic epistasis with Hoxa3/Hoxd3 double knockout mice and skeletal analysis","pmids":["7913519"],"confidence":"High","gaps":["Molecular target genes mediating the proliferation effect not identified","Direct DNA-binding evidence absent"]},{"year":1995,"claim":"Defined the core developmental phenotype, showing Hoxa3 loss causes athymia and thyroid hypoplasia through effects on differentiation, not neural crest migration, and maintains Pax1 in third-pouch neural crest.","evidence":"Knockout mouse with carbocyanine dye tracing, molecular markers, and in situ hybridization","pmids":["7635047"],"confidence":"High","gaps":["Whether Pax1 regulation is direct not established","Cell-autonomy not yet resolved"]},{"year":1999,"claim":"Identified the upstream initiator of Hoxa3 hindbrain expression, showing Krml1/kreisler directly binds a defined enhancer to drive r5/r6 expression.","evidence":"Transgenic enhancer analysis, EMSA binding-site mapping, and kreisler mutant embryos","pmids":["9895323"],"confidence":"High","gaps":["Maintenance phase of expression not explained by this element","Downstream hindbrain targets unknown"]},{"year":2001,"claim":"Resolved the Hoxa3-Pax1 pathway in thymus/parathyroid organogenesis, localizing the defect to radio-resistant epithelial stroma and linking it to epithelial death, proliferation, and Gcm2/Foxn1 marker expression.","evidence":"Compound mutant mice, fetal liver adoptive transfer, flow cytometry, and organ-specific in situ markers","pmids":["10820253","11476574"],"confidence":"High","gaps":["Direct transcriptional targets of Hoxa3 in epithelium not identified","Mechanism of apoptosis induction unknown"]},{"year":2001,"claim":"Showed that sustained r5/r6 expression is maintained independently of kreisler by conserved bipartite Hox/Pbx sites mediating auto/cross-regulatory feedback.","evidence":"Transgenic mouse and chick analysis with deletion and Hox/Pbx site mutagenesis across species","pmids":["11566863"],"confidence":"High","gaps":["Identity of the specific Hox/Pbx partners binding in vivo not defined"]},{"year":2002,"claim":"Extended the developmental role to vascular structures, showing Hoxa3 is required for carotid body formation via maintenance of the third arch artery.","evidence":"Knockout mouse histology and immunohistochemistry with complete penetrance","pmids":["12074562"],"confidence":"High","gaps":["Molecular effectors of arch artery maintenance unknown","Cell type executing the requirement not pinpointed"]},{"year":2003,"claim":"Demonstrated Hoxa3 is not only necessary but sufficient to specify somatic motoneurone identity, acting upstream of the patterning gene Irx3.","evidence":"Rhombomere transplantation and targeted gain-of-function with Irx3 in situ readout","pmids":["12756180"],"confidence":"Medium","gaps":["Single study","Whether Irx3 repression is direct not tested"]},{"year":2004,"claim":"Localized the parathyroid requirement cell-autonomously to pouch endoderm, separating it from neural crest migration.","evidence":"Knockout mouse with SP-1/chromogranin A immunohistochemistry and connexin43-lacZ crest tracing","pmids":["15100241"],"confidence":"Medium","gaps":["Single lab","Endoderm-intrinsic target genes not identified"]},{"year":2005,"claim":"Identified an angiogenic effector function, showing HOXA3 drives endothelial and keratinocyte migration and wound angiogenesis via uPAR-dependent induction of MMP-14 and uPAR.","evidence":"In vitro migration assays, in vivo gene transfer into diabetic wounds, and uPAR blocking","pmids":["15914537"],"confidence":"High","gaps":["Whether MMP-14/uPAR are direct transcriptional targets not shown","Connection to developmental role unclear"]},{"year":2009,"claim":"Showed HOXA3 reshapes the wound cellular environment by recruiting endothelial progenitors and suppressing pro-inflammatory NF-κB pathway members.","evidence":"GFP bone marrow chimeras, in vivo gene transfer, flow cytometry, and microarray","pmids":["19544454"],"confidence":"Medium","gaps":["Directness of MyD88/TOLLIP repression untested","Single lab"]},{"year":2010,"claim":"Established HOXA3 as an apical regulator of the endothelial-to-hematopoietic transition by repressing Runx1 and other hematopoietic factors, and showed it promotes proangiogenic myeloid differentiation that rescues the diabetic phenotype.","evidence":"Reciprocal loss/gain-of-function with epistasis, expression profiling, and ex vivo/in vivo functional rescue","pmids":["21170035","20974673"],"confidence":"High","gaps":["Whether Runx1 repression is direct binding not shown in this work","Mechanism of myeloid reprogramming undefined"]},{"year":2010,"claim":"Mapped functional divergence between orthologs to the protein C-terminal domain, indicating tissue-specific activity resides outside the homeodomain.","evidence":"Knock-in of zebrafish hoxa3a at the mouse locus and chimeric protein allele with tissue rescue analysis","pmids":["20498049"],"confidence":"High","gaps":["Biochemical basis of C-terminal specificity unknown","Cofactor differences not identified"]},{"year":2014,"claim":"Dissected cell-autonomous versus non-autonomous roles, showing endoderm-intrinsic function in thymus/parathyroid and crest-based morphogenetic function, with combined deletion phenocopying the null.","evidence":"Tissue-specific and double conditional knockouts with Hoxa3-Cre lineage tracing","pmids":["25249461","27178667"],"confidence":"High","gaps":["Lineage-specific direct targets not enumerated","Temporal target switching unresolved"]},{"year":2016,"claim":"Showed HOXA3 controls macrophage polarization, suppressing M1 and promoting M2 states via Pu.1/Spi1 and Stat6 in a DNA-binding-independent manner.","evidence":"Protein transduction in vitro, in vivo gene transfer, Western blot, and immunofluorescence of polarization markers","pmids":["27342843"],"confidence":"Medium","gaps":["Non-DNA-binding mechanism not molecularly defined","Single lab"]},{"year":2017,"claim":"Defined the HoxA3-Notch link, showing it induces Jagged1 to cis-inhibit Notch and render hemogenic endothelium non-responsive, a prerequisite step preceding EHT.","evidence":"Gain-of-function with Notch activation/inhibition, Jag1 knockdown, and expression/phenotype assays","pmids":["29073173"],"confidence":"Medium","gaps":["Whether Jag1 is a direct transcriptional target not confirmed","Single lab"]},{"year":2019,"claim":"Connected HOXA3 to inflammatory and chromatin regulation, rescuing diabetic human macrophage defects through Runx1 upregulation and modulation of NF-κB and TNF promoter acetylation.","evidence":"Protein transduction, Western blot, HAT/HDAC activity assay, and ChIP of TNF promoter acetylation in primary human cells","pmids":["31626638"],"confidence":"Medium","gaps":["Direct versus indirect Runx1 regulation unresolved (contrasts with hematopoietic repression)","Single lab"]},{"year":2020,"claim":"Placed HOXA3 in a GDF11/Smad2/3 axis as a direct transcriptional repressor of NLRP3 that limits cardiomyocyte pyroptosis.","evidence":"ChIP assay, AAV9 in vivo overexpression, and Smad pathway Western blot","pmids":["33100331"],"confidence":"Medium","gaps":["Generalizability beyond cardiomyocytes unknown","Single lab"]},{"year":2021,"claim":"Identified an antiviral-suppressive role in which HOXA3 represses HO-1 transcription, weakening HO-1-IRF3 interaction and dampening type I interferon production.","evidence":"Luciferase reporter, knockdown/overexpression, Co-IP, and IRF3 phosphorylation/translocation assays during PRRSV infection","pmids":["34851144"],"confidence":"Medium","gaps":["Direct HOXA3 binding to HO-1 promoter via ChIP not shown","Single lab"]},{"year":2021,"claim":"Revealed translational control of HOXA3 itself through a 5'UTR uORF-based Translation Inhibitory Element requiring eIF2D, with an IRES enabling cap-independent translation.","evidence":"In vitro translation, uORF mutagenesis, eIF2D requirement, and reporter assays","pmids":["34076576"],"confidence":"High","gaps":["Physiological contexts engaging the TIE versus IRES unknown","In vivo relevance not established"]},{"year":2021,"claim":"Reported that HOXA2 and HOXA3 can heterodimerize, raising the possibility of combinatorial control of HOX binding specificity.","evidence":"ChIP-seq, in vitro binding assays, and protein-protein interaction assay","pmids":["34940502"],"confidence":"Low","gaps":["Functional consequences of heterodimerization not directly tested","Single method for the interaction","In vivo relevance unverified"]},{"year":2024,"claim":"Established a HOXA3/USP15/SQSTM1 axis in which HOXA3 directly activates USP15 to suppress autophagy and promote M2 polarization and tumor growth in renal cell carcinoma.","evidence":"ChIP, EMSA, dual-luciferase, Co-IP, ubiquitination assay, autophagy imaging, and xenograft","pmids":["39740793"],"confidence":"Medium","gaps":["Generality across tumor types untested","Single lab"]},{"year":2024,"claim":"Extended the developmental role to a human model, showing HOXA3 controls third pharyngeal pouch endoderm commitment via Wnt signaling through transcriptional activation of EPHB2.","evidence":"hESC differentiation with HOXA3 knockdown, Wnt reporter, and proliferation/migration assays","pmids":["38259452"],"confidence":"Medium","gaps":["Direct EPHB2 binding not fully resolved","In vivo human relevance not established"]},{"year":2024,"claim":"Positioned HOXA3 as a downstream effector of isoform-specific WT1, mediating G1 arrest and cytarabine resistance in AML.","evidence":"RNA-seq, HOXA3 overexpression, cell-cycle/CD71 flow cytometry, and chemoresistance assays","pmids":["38867543"],"confidence":"Medium","gaps":["HOXA3 transcriptional targets driving resistance not identified","Single lab"]},{"year":null,"claim":"The unifying biochemical question — what cofactors and direct genome-wide target sets allow one homeodomain factor to switch between developmental patterning, hematovascular fate, and inflammatory/tumor programs — remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No comprehensive genome-wide HOXA3 binding map across cell types","C-terminal specificity determinants not mechanistically explained","Reconciliation of context-dependent Runx1 repression versus activation unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[12,20,24,25]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,4,24]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[24]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,5,6,15,17,25]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,4,12,24]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[16,19,20,24]}],"complexes":[],"partners":["HOXA2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O43365","full_name":"Homeobox protein Hox-A3","aliases":["Homeobox protein Hox-1E"],"length_aa":443,"mass_kda":46.4,"function":"Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O43365/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HOXA3","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HOXA3","total_profiled":1310},"omim":[{"mim_id":"616068","title":"HOXA CLUSTER ANTISENSE RNA 2, NONCODING; HOXAAS2","url":"https://www.omim.org/entry/616068"},{"mim_id":"142980","title":"HOMEOBOX D3; HOXD3","url":"https://www.omim.org/entry/142980"},{"mim_id":"142954","title":"HOMEOBOX A3; HOXA3","url":"https://www.omim.org/entry/142954"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HOXA3"},"hgnc":{"alias_symbol":[],"prev_symbol":["HOX1E","HOX1"]},"alphafold":{"accession":"O43365","domains":[{"cath_id":"1.10.10.60","chopping":"199-252","consensus_level":"medium","plddt":97.1807,"start":199,"end":252}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43365","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43365-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43365-F1-predicted_aligned_error_v6.png","plddt_mean":57.84},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HOXA3","jax_strain_url":"https://www.jax.org/strain/search?query=HOXA3"},"sequence":{"accession":"O43365","fasta_url":"https://rest.uniprot.org/uniprotkb/O43365.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43365/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43365"}},"corpus_meta":[{"pmid":"7635047","id":"PMC_7635047","title":"The role of Hoxa-3 in mouse thymus and thyroid development.","date":"1995","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7635047","citation_count":355,"is_preprint":false},{"pmid":"7913519","id":"PMC_7913519","title":"Mice with targeted disruptions in the paralogous genes hoxa-3 and hoxd-3 reveal synergistic interactions.","date":"1994","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7913519","citation_count":226,"is_preprint":false},{"pmid":"11476574","id":"PMC_11476574","title":"Hoxa3 and pax1 regulate epithelial cell death and proliferation during thymus and parathyroid organogenesis.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11476574","citation_count":114,"is_preprint":false},{"pmid":"15914537","id":"PMC_15914537","title":"HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair.","date":"2005","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15914537","citation_count":108,"is_preprint":false},{"pmid":"9895323","id":"PMC_9895323","title":"Conserved and distinct roles of kreisler in regulation of the paralogous Hoxa3 and Hoxb3 genes.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9895323","citation_count":103,"is_preprint":false},{"pmid":"11566863","id":"PMC_11566863","title":"Independent regulation of initiation and maintenance phases of Hoxa3 expression in the vertebrate hindbrain involve auto- and cross-regulatory mechanisms.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11566863","citation_count":85,"is_preprint":false},{"pmid":"21170035","id":"PMC_21170035","title":"HoxA3 is an apical regulator of haemogenic endothelium.","date":"2010","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21170035","citation_count":68,"is_preprint":false},{"pmid":"33100331","id":"PMC_33100331","title":"GDF11 inhibits cardiomyocyte pyroptosis and exerts cardioprotection in acute myocardial infarction mice by upregulation of transcription factor HOXA3.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33100331","citation_count":66,"is_preprint":false},{"pmid":"31615976","id":"PMC_31615976","title":"LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells.","date":"2019","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31615976","citation_count":62,"is_preprint":false},{"pmid":"10820253","id":"PMC_10820253","title":"Hoxa3 and pax1 transcription factors regulate the ability of fetal thymic epithelial cells to promote thymocyte development.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10820253","citation_count":61,"is_preprint":false},{"pmid":"30375256","id":"PMC_30375256","title":"LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis.","date":"2019","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30375256","citation_count":59,"is_preprint":false},{"pmid":"9894676","id":"PMC_9894676","title":"Retinoic acid-induced thymic abnormalities in the mouse are associated with altered pharyngeal morphology, thymocyte maturation defects, and altered expression of Hoxa3 and Pax1.","date":"1998","source":"Teratology","url":"https://pubmed.ncbi.nlm.nih.gov/9894676","citation_count":54,"is_preprint":false},{"pmid":"8631267","id":"PMC_8631267","title":"Rhombomere of origin determines autonomous versus environmentally regulated expression of Hoxa-3 in the avian embryo.","date":"1996","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8631267","citation_count":54,"is_preprint":false},{"pmid":"12074562","id":"PMC_12074562","title":"Homeobox gene hoxa3 is essential for the formation of the carotid body in the mouse embryos.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12074562","citation_count":53,"is_preprint":false},{"pmid":"29073728","id":"PMC_29073728","title":"HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29073728","citation_count":47,"is_preprint":false},{"pmid":"12756180","id":"PMC_12756180","title":"Somatic motoneurone specification in the hindbrain: the influence of somite-derived signals, retinoic acid and Hoxa3.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12756180","citation_count":45,"is_preprint":false},{"pmid":"25249461","id":"PMC_25249461","title":"Multiple roles for HOXA3 in regulating thymus and parathyroid differentiation and morphogenesis in mouse.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25249461","citation_count":38,"is_preprint":false},{"pmid":"15714286","id":"PMC_15714286","title":"Hoxa3 regulates the proliferation and differentiation of the third pharyngeal arch mesenchyme in mice.","date":"2005","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/15714286","citation_count":38,"is_preprint":false},{"pmid":"19544454","id":"PMC_19544454","title":"HOXA3 modulates injury-induced mobilization and recruitment of bone marrow-derived cells.","date":"2009","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/19544454","citation_count":36,"is_preprint":false},{"pmid":"19290546","id":"PMC_19290546","title":"Hoxa3 and signaling molecules involved in aortic arch patterning and remodeling.","date":"2009","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/19290546","citation_count":35,"is_preprint":false},{"pmid":"20974673","id":"PMC_20974673","title":"Hoxa3 promotes the differentiation of hematopoietic progenitor cells into proangiogenic Gr-1+CD11b+ myeloid cells.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20974673","citation_count":35,"is_preprint":false},{"pmid":"12658442","id":"PMC_12658442","title":"Disruption of the Hoxa3 homeobox gene results in anomalies of the carotid artery system and the arterial baroreceptors.","date":"2003","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/12658442","citation_count":33,"is_preprint":false},{"pmid":"30551418","id":"PMC_30551418","title":"TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30551418","citation_count":30,"is_preprint":false},{"pmid":"30066858","id":"PMC_30066858","title":"Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.","date":"2018","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30066858","citation_count":29,"is_preprint":false},{"pmid":"15100241","id":"PMC_15100241","title":"The role of Hoxa3 gene in parathyroid gland organogenesis of the mouse.","date":"2004","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/15100241","citation_count":29,"is_preprint":false},{"pmid":"20498049","id":"PMC_20498049","title":"Mouse and zebrafish Hoxa3 orthologues have nonequivalent in vivo protein function.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20498049","citation_count":28,"is_preprint":false},{"pmid":"27342843","id":"PMC_27342843","title":"Enforced Expression of Hoxa3 Inhibits Classical and Promotes Alternative Activation of Macrophages In Vitro and In Vivo.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27342843","citation_count":28,"is_preprint":false},{"pmid":"22110697","id":"PMC_22110697","title":"A retinoic acid responsive Hoxa3 transgene expressed in embryonic pharyngeal endoderm, cardiac neural crest and a subdomain of the second heart field.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22110697","citation_count":27,"is_preprint":false},{"pmid":"34851144","id":"PMC_34851144","title":"Induction of HOXA3 by Porcine Reproductive and Respiratory Syndrome Virus Inhibits Type I Interferon Response through Negative Regulation of HO-1 Transcription.","date":"2021","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/34851144","citation_count":26,"is_preprint":false},{"pmid":"11784044","id":"PMC_11784044","title":"Hoxa3 regulates integration of glossopharyngeal nerve precursor cells.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11784044","citation_count":26,"is_preprint":false},{"pmid":"30975094","id":"PMC_30975094","title":"miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinoma.","date":"2019","source":"BMC nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/30975094","citation_count":23,"is_preprint":false},{"pmid":"27178667","id":"PMC_27178667","title":"Temporal and spatial requirements for Hoxa3 in mouse embryonic development.","date":"2016","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/27178667","citation_count":20,"is_preprint":false},{"pmid":"30604847","id":"PMC_30604847","title":"Hox genes in the pharyngeal region: how Hoxa3 controls early embryonic development of the pharyngeal organs.","date":"2018","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/30604847","citation_count":18,"is_preprint":false},{"pmid":"33683826","id":"PMC_33683826","title":"ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33683826","citation_count":18,"is_preprint":false},{"pmid":"31626638","id":"PMC_31626638","title":"Dysregulation of macrophage development and phenotype in diabetic human macrophages can be rescued by Hoxa3 protein transduction.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31626638","citation_count":18,"is_preprint":false},{"pmid":"27178573","id":"PMC_27178573","title":"Chicken gga-miR-130a targets HOXA3 and MDFIC and inhibits Marek's disease lymphoma cell proliferation and migration.","date":"2016","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27178573","citation_count":16,"is_preprint":false},{"pmid":"32926751","id":"PMC_32926751","title":"LINC00689 induces gastric cancer progression via modulating the miR-338-3p/HOXA3 axis.","date":"2020","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32926751","citation_count":16,"is_preprint":false},{"pmid":"12241558","id":"PMC_12241558","title":"Stage-specific changes in fetal thymocyte proliferation during the CD4-8- to CD4+8+ transition in wild type, Rag1-/-, and Hoxa3,Pax1 mutant mice.","date":"2002","source":"BMC immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12241558","citation_count":11,"is_preprint":false},{"pmid":"17211587","id":"PMC_17211587","title":"Expression of homeotic genes Hoxa3, Hoxb3, Hoxd3 and Hoxc4 is decreased in the lungs but not in the hearts of adriamycin-exposed mice.","date":"2007","source":"Pediatric surgery international","url":"https://pubmed.ncbi.nlm.nih.gov/17211587","citation_count":10,"is_preprint":false},{"pmid":"34076576","id":"PMC_34076576","title":"Translation inhibitory elements from Hoxa3 and Hoxa11 mRNAs use uORFs for translation inhibition.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34076576","citation_count":10,"is_preprint":false},{"pmid":"21278919","id":"PMC_21278919","title":"Chicken HOXA3 gene: its expression pattern and role in branchial nerve precursor cell migration.","date":"2011","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21278919","citation_count":9,"is_preprint":false},{"pmid":"38259452","id":"PMC_38259452","title":"HOXA3 functions as the on-off switch to regulate the development of hESC-derived third pharyngeal pouch endoderm through EPHB2-mediated Wnt pathway.","date":"2024","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38259452","citation_count":8,"is_preprint":false},{"pmid":"31322185","id":"PMC_31322185","title":"miR‑338‑3p suppresses the malignancy of T‑cell lymphoblastic lymphoma by downregulating HOXA3.","date":"2019","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/31322185","citation_count":7,"is_preprint":false},{"pmid":"37337031","id":"PMC_37337031","title":"HOXA3 accelerates wound healing in diabetic and aged non-diabetic mammals.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37337031","citation_count":6,"is_preprint":false},{"pmid":"25302136","id":"PMC_25302136","title":"Secreted HoxA3 Promotes Epidermal Proliferation and Angiogenesis in Genetically Modified Three-Dimensional Composite Skin Constructs.","date":"2014","source":"Advances in wound care","url":"https://pubmed.ncbi.nlm.nih.gov/25302136","citation_count":6,"is_preprint":false},{"pmid":"37119247","id":"PMC_37119247","title":"ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia.","date":"2023","source":"The Malaysian journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/37119247","citation_count":5,"is_preprint":false},{"pmid":"39658479","id":"PMC_39658479","title":"Epigenetic regulation of HOXA3 and its impact on oral squamous cell carcinoma progression.","date":"2024","source":"Oral surgery, oral medicine, oral pathology and oral radiology","url":"https://pubmed.ncbi.nlm.nih.gov/39658479","citation_count":4,"is_preprint":false},{"pmid":"29073173","id":"PMC_29073173","title":"Notch activation is required for downregulation of HoxA3-dependent endothelial cell phenotype during blood formation.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29073173","citation_count":4,"is_preprint":false},{"pmid":"40107921","id":"PMC_40107921","title":"High expression and regulatory mechanisms of ANGPT1 and HOXA3 in acute myeloid leukemia.","date":"2025","source":"Bulletin du cancer","url":"https://pubmed.ncbi.nlm.nih.gov/40107921","citation_count":3,"is_preprint":false},{"pmid":"38867543","id":"PMC_38867543","title":"Upregulation of HOXA3 by isoform-specific Wilms tumour 1 drives chemotherapy resistance in acute myeloid leukaemia.","date":"2024","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/38867543","citation_count":3,"is_preprint":false},{"pmid":"34940502","id":"PMC_34940502","title":"Molecular Characterization of HOXA2 and HOXA3 Binding Properties.","date":"2021","source":"Journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34940502","citation_count":3,"is_preprint":false},{"pmid":"24127533","id":"PMC_24127533","title":"The absence of mutations in homeobox candidate genes HOXA3, HOXB3, HOXD3 and PITX2 in familial and sporadic thyroid hemiagenesis.","date":"2014","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/24127533","citation_count":3,"is_preprint":false},{"pmid":"28667681","id":"PMC_28667681","title":"Escapees from Rhombomeric Lineage Restriction: Extensive Migration Rostral to the r4/r5 Border of Hox-a3 Expression.","date":"2017","source":"Anatomical record (Hoboken, N.J. : 2007)","url":"https://pubmed.ncbi.nlm.nih.gov/28667681","citation_count":3,"is_preprint":false},{"pmid":"39012095","id":"PMC_39012095","title":"Expression profiling by high-throughput sequencing reveals GADD45, SMAD7, EGR-1 and HOXA3 activation in Myostatin (MSTN) and GDF11 treated myoblasts.","date":"2024","source":"Genetics and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/39012095","citation_count":2,"is_preprint":false},{"pmid":"39740793","id":"PMC_39740793","title":"HOXA3 activates USP15 to suppress autophagy and promote M2-type macrophage polarization in renal cell carcinoma via facilitating the deubiquitination of SQSTM1.","date":"2024","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/39740793","citation_count":0,"is_preprint":false},{"pmid":"41609866","id":"PMC_41609866","title":"Acute myeloid leukemia (AML)-derived bone mesenchymal stem cell exosomal METTL14 promotes AML cell growth and glycolysis by HOXA3/WNT7B axis.","date":"2026","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/41609866","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.17.688316","title":"Dynamic methylation changes in Alzheimer’s disease-related genes during mindfulness practice – a proof-of-concept study","date":"2025-11-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.17.688316","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":30586,"output_tokens":7047,"usd":0.098731,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16193,"output_tokens":6000,"usd":0.115483,"stage2_stop_reason":"end_turn"},"total_usd":0.214214,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"Targeted disruption of Hoxa3 results in athymia and thyroid hypoplasia; analysis with carbocyanine dye and molecular markers showed neural crest migration was not grossly affected, indicating Hoxa3 affects the intrinsic capacity of neural crest cells to differentiate and/or induce proper differentiation of surrounding pharyngeal tissues. Hoxa3 loss causes a marked reduction in Pax1 expression in neural crest cells of the 3rd pharyngeal pouch, suggesting Hoxa3 is required to maintain Pax1 expression as part of the athymic phenotype.\",\n      \"method\": \"Gene targeting (knockout mouse), carbocyanine dye injection, molecular marker analysis, in situ hybridization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — loss-of-function mouse model with multiple orthogonal methods (dye tracing, molecular markers, in situ hybridization), replicated in subsequent studies\",\n      \"pmids\": [\"7635047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Hoxa3 and Hoxd3 show synergistic, dosage-dependent interactions: double mutants show deletion of the entire atlas rather than simple homeotic transformation seen in single Hoxd3 mutants, interpreted as differential regulation of proliferation rates of precursor cells.\",\n      \"method\": \"Genetic epistasis (double knockout mice), skeletal analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with double mutants clearly establishing synergistic interaction, published in high-impact journal with rigorous controls\",\n      \"pmids\": [\"7913519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Hoxa3 expression in rhombomeres 5 and 6 of the hindbrain is directly regulated by the Maf bZIP transcription factor Krml1 (kreisler): a single high-affinity Krml1 binding site in a 600 bp enhancer in the Hoxa3/Hoxa4 intergenic region is necessary and sufficient for r5/r6 expression, and this activity depends on endogenous kreisler.\",\n      \"method\": \"Transgenic enhancer analysis, deletion mapping, electrophoretic mobility shift assay (binding site identification), ectopic kreisler expression, kreisler mutant analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (transgenic analysis, binding site mutagenesis, genetic loss-of-function), replicated with kreisler mutant embryos\",\n      \"pmids\": [\"9895323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hoxa3 and Pax1 act synergistically in a genetic pathway required for thymic epithelial cell development: Hoxa3(+/-)Pax1(-/-) compound mutants show defective MHC class II+ epithelial cells, reduced thymocyte maturation with a block at CD4-8- to CD4+8+ transition, and increased apoptosis of CD4+8+ thymocytes. Fetal liver adoptive transfer showed the defect resides in radio-resistant stromal (epithelial) cells, not hematopoietic cells.\",\n      \"method\": \"Compound mutant mice (genetic epistasis), fetal liver adoptive transfer, flow cytometry, immunohistochemistry\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with compound mutants, cell-type specificity established by adoptive transfer, multiple orthogonal readouts\",\n      \"pmids\": [\"10820253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Maintenance of Hoxa3 expression in r5 and r6 during late hindbrain development is controlled by a conserved cis-element containing two bipartite Hox/Pbx-binding sites that mediate auto- and cross-regulatory feedback loops, independently of kreisler. This element is conserved in human and horn shark Hoxa3 loci.\",\n      \"method\": \"Transgenic analysis in mouse and chick embryos, deletion analysis of cis-regulatory elements, site-directed mutagenesis of Hox/Pbx binding sites\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — regulatory element characterized by transgenic analysis, mutagenesis of binding sites, cross-species conservation, and in vivo functional validation\",\n      \"pmids\": [\"11566863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hoxa3 and Pax1 regulate epithelial cell death and proliferation during thymus and parathyroid organogenesis: compound mutants show increased apoptosis in the forming primordium, and Gcm2 (parathyroid marker) expression is progressively lost while thymus-specific Foxn1 initiates normally but thymic epithelial cells die. The Hoxa3-Pax1 pathway is required for both epithelial cell growth and differentiation.\",\n      \"method\": \"Compound mutant mice, immunohistochemistry, in situ hybridization for organ-specific markers (Gcm2, Foxn1), apoptosis assays\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — compound mutant genetic pathway analysis with specific molecular marker readouts, replicated across multiple studies\",\n      \"pmids\": [\"11476574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hoxa3 is essential for formation of the carotid body; in null mutants, the third arch artery degenerates bilaterally beginning at E10.5, leading to malformation of the carotid artery system and absence of carotid body. Neural crest cell migration to the third arch was not affected.\",\n      \"method\": \"Knockout mouse analysis, histology, immunohistochemistry\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complete penetrance (10/10 mutants) loss-of-function with defined cellular mechanism (third arch artery degeneration), replicated in subsequent studies\",\n      \"pmids\": [\"12074562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Targeted overexpression of Hoxa3 in the rostral hindbrain (r1-4) leads to generation of ectopic somatic motoneurones and repression of the dorsoventral patterning gene Irx3, demonstrating Hoxa3 is sufficient to specify somatic motoneurone identity and acts upstream of Irx3.\",\n      \"method\": \"Heterotopic rhombomere transplantation, targeted overexpression (gain-of-function), in situ hybridization for Irx3\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with molecular readout (Irx3 repression), single study\",\n      \"pmids\": [\"12756180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Hoxa3 null mutation prevents differentiation of the third pharyngeal pouch into the parathyroid rudiment (absence of SP-1/chromogranin A immunoreactivity at E11.5), while neural crest cell migration to surround the third pouch epithelium is unaffected, indicating Hoxa3 acts cell-autonomously in pouch endoderm for parathyroid initiation.\",\n      \"method\": \"Knockout mouse, immunohistochemistry (SP-1/chromogranin A), connexin43-lacZ transgene for neural crest cell visualization\",\n      \"journal\": \"Journal of Histochemistry and Cytochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with specific molecular marker and cell-lineage tracing, single lab\",\n      \"pmids\": [\"15100241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HOXA3 promotes endothelial cell migration and angiogenesis in vivo, and increases expression of MMP-14 and uPAR genes in endothelial cells in culture and in vivo during wound healing. HOXA3-induced migration of endothelial cells and keratinocytes is uPAR-dependent. Gene transfer of HOXA3 into diabetic mouse wounds improves angiogenesis and wound closure.\",\n      \"method\": \"Gene transfer (in vivo), endothelial cell migration assay, angiogenesis assay in vivo, gene expression analysis (MMP-14, uPAR), uPAR blocking experiments\",\n      \"journal\": \"Journal of Cell Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (in vitro migration assay, in vivo gene transfer, pathway blocking with uPAR), replicated in subsequent studies\",\n      \"pmids\": [\"15914537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Hoxa3 is required for proliferation and differentiation of the third pharyngeal arch mesenchyme: null mutants show delayed fusion of the third pharyngeal arch with the second and fourth arches, reduced number of proliferating cells in the third arch, and regression of the third arch artery at E11.5. Neural crest cell migration to the third arch is not affected.\",\n      \"method\": \"Knockout mouse with connexin43-lacZ neural crest reporter, BrdU proliferation assay, whole-mount X-gal staining, immunohistochemistry\",\n      \"journal\": \"Cell and Tissue Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with cell-lineage tracing and proliferation assay, single lab\",\n      \"pmids\": [\"15714286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HOXA3 expression in diabetic mouse wounds significantly increases mobilization and recruitment of endothelial progenitor cells (bone marrow-derived) while reducing inflammatory cell recruitment. HOXA3 locally suppresses expression of pro-inflammatory NF-κB pathway members (MyD88, TOLLIP) as identified by microarray.\",\n      \"method\": \"GFP bone marrow chimeras, gene transfer (in vivo), flow cytometry, microarray gene expression analysis\",\n      \"journal\": \"Stem Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo cell-tracking with BM chimeras and gene expression profiling, single lab\",\n      \"pmids\": [\"19544454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HoxA3 restrains haematopoietic differentiation of hemogenic endothelium by downregulating key haematopoietic transcription factors including Runx1, Gata1, Gfi1B, Ikaros, and PU.1. Loss-of-function and gain-of-function epistasis experiments showed that Runx1 is uniquely able to erase the endothelial program set up by HoxA3, establishing HoxA3 as an apical regulator of the endothelial-to-hematopoietic transition.\",\n      \"method\": \"Loss-of-function and gain-of-function experiments, epistasis analysis, gene expression profiling, cell fate assays (CD41 marker)\",\n      \"journal\": \"Nature Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal loss- and gain-of-function with epistasis, multiple target transcription factors identified, published in high-impact journal\",\n      \"pmids\": [\"21170035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hoxa3 promotes differentiation of hematopoietic progenitor cells into proangiogenic Gr-1+CD11b+ myeloid cells; sustained Hoxa3 expression in diabetic-derived Gr-1+CD11b+ cells reverses their diabetic phenotype (restoring proliferation, chemotaxis, adhesion, and differentiation) and stimulates neovascularization in vivo.\",\n      \"method\": \"Gene transfer (ex vivo and in vivo), flow cytometry, proliferation/chemotaxis/adhesion assays, in vivo angiogenesis assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional rescue experiments in primary cells with in vivo validation, single lab\",\n      \"pmids\": [\"20974673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mouse and zebrafish Hoxa3a proteins have nonequivalent in vivo function: zebrafish hoxa3a expressed from the mouse Hoxa3 locus can substitute for mouse Hoxa3 in some tissues but not others, and the functional difference maps primarily to the C-terminal domain of the protein, as shown by a chimeric protein allele.\",\n      \"method\": \"Knock-in mouse (zebrafish hoxa3a expressed from mouse locus), chimeric protein allele, tissue-specific phenotypic rescue analysis\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — chimeric protein allele directly maps functional divergence to C-terminal domain, multiple tissue readouts in vivo\",\n      \"pmids\": [\"20498049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Tissue-specific deletion experiments show Hoxa3 has distinct cell-autonomous roles: in endoderm, it temporally regulates initiation of the thymus program and is required cell-autonomously for parathyroid differentiation; in neural crest cells, it is primarily required for morphogenesis (organ migration). Expression in either tissue alone is sufficient for organ survival, while simultaneous deletion in both endoderm and NCC leads to athymia similar to the null.\",\n      \"method\": \"Tissue-specific conditional knockout (endoderm-Cre, NCC-Cre, double Cre), lineage analysis with Hoxa3-Cre, marker expression analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple tissue-specific Cre knockouts with clear cell-autonomous vs non-autonomous distinctions, supported by lineage tracing\",\n      \"pmids\": [\"25249461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hoxa3 protein transduction in macrophages enhances macrophage maturation, inhibits M1 (classical) polarization, and promotes M2 (alternative) polarization, in part via regulation of Pu.1/Spi1 and Stat6. In vivo, sustained Hoxa3 expression reduces Nos2+ (M1-like) macrophages and increases Arg1+/VEGF+ (M2-like) macrophages in diabetic wounds. This phenotypic switching occurs in a DNA-binding independent manner.\",\n      \"method\": \"Protein transduction in vitro, in vivo gene transfer, flow cytometry, Western blot (Pu.1, Stat6), immunofluorescence (Nos2, Arg1, VEGF)\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo protein transduction with mechanistic pathway readouts (Pu.1, Stat6), single lab\",\n      \"pmids\": [\"27342843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Comprehensive temporal/spatial analysis shows HOXA3 functions in both cell-autonomous and non-cell-autonomous manners: cell-autonomously in tracheal epithelium, thymus, and parathyroid endodermal cells for differentiation; non-cell-autonomously in NCCs for structures that are Hoxa3-lineage-negative. These defects reflect roles in differentiation and morphogenesis programs rather than positional identity.\",\n      \"method\": \"Temporal conditional knockout (tamoxifen-inducible Cre), tissue-specific Cre, Hoxa3-Cre lineage tracing, marker expression analysis\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — comprehensive conditional knockout series with lineage tracing providing clear cell-autonomous vs non-autonomous distinctions across multiple structures\",\n      \"pmids\": [\"27178667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HoxA3 inhibits the Notch pathway in hemogenic endothelium by inducing upregulation of the Jagged1 (Jag1) ligand, which causes cis-inhibition of Notch signaling, rendering hemogenic endothelial cells non-responsive to Notch signals. Notch activation or Jag1 downregulation is required to downregulate endothelial markers as a prerequisite for endothelial-to-hematopoietic transition (EHT).\",\n      \"method\": \"Gain-of-function (HoxA3 overexpression), Notch pathway activation/inhibition, Jag1 knockdown, gene expression analysis, cell phenotype assays\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic dissection of HoxA3-Notch-Jag1 axis with multiple interventions, single lab building on prior work\",\n      \"pmids\": [\"29073173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Diabetic-derived human macrophages show maturation defects associated with reduced RUNX1 expression. Protein transduction of Hoxa3 rescues inflammation and maturation defects in diabetic human macrophages via upregulation of Runx1, and also modulates p65/NF-κB levels, histone acetyltransferase/deacetylase activity, and inhibits acetylation of the TNF promoter.\",\n      \"method\": \"Protein transduction, Western blot (RUNX1, p65/NF-κB), histone acetyltransferase/deacetylase activity assay, chromatin immunoprecipitation (TNF promoter acetylation), flow cytometry\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal mechanistic readouts in primary human cells, single lab\",\n      \"pmids\": [\"31626638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GDF11 promotes HOXA3 expression via Smad2/3 pathway activation, and HOXA3 negatively regulates NLRP3 inflammasome expression; HOXA3 was confirmed as a transcriptional regulator of NLRP3 by ChIP assay, forming a GDF11/Smad2/3/HOXA3/NLRP3 signaling pathway that inhibits cardiomyocyte pyroptosis.\",\n      \"method\": \"ChIP assay, AAV9-mediated gene overexpression in vivo, Western blot (Smad2/3 pathway), gene knockdown/overexpression\",\n      \"journal\": \"Cell Death & Disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP assay establishes direct HOXA3-NLRP3 transcriptional regulation, in vivo validation, single lab\",\n      \"pmids\": [\"33100331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HOXA3 negatively regulates transcription of the HO-1 (heme oxygenase-1) gene; PRRSV induces HOXA3 upregulation, which suppresses HO-1 transcription, thereby weakening HO-1-IRF3 interaction, reducing IRF3 phosphorylation and nuclear translocation, and suppressing type I interferon (IFN-β and ISG) production.\",\n      \"method\": \"Luciferase reporter assay (HO-1 promoter), gene knockdown/overexpression, co-immunoprecipitation (HO-1-IRF3), Western blot (IRF3 phosphorylation, nuclear translocation), viral infection assay\",\n      \"journal\": \"Journal of Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (reporter assay, Co-IP, phosphorylation analysis) establishing mechanistic pathway, single lab\",\n      \"pmids\": [\"34851144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The Hoxa3 5'UTR contains an upstream ORF (uORF) that is critical for inhibiting cap-dependent translation of Hoxa3 mRNA, forming a Translation Inhibitory Element (TIE). The non-canonical initiation factor eIF2D is required for this uORF-mediated cap-dependent translation inhibition, while an IRES in the same 5'UTR enables cap-independent translation.\",\n      \"method\": \"In vitro translation assay, uORF mutagenesis, eIF2D requirement experiments, reporter assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis of the uORF and identification of specific initiation factor (eIF2D), single lab but multiple orthogonal biochemical methods\",\n      \"pmids\": [\"34076576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HOXA2 and HOXA3 can heterodimerise, which may have functional consequences for HOX patterning in vivo. In vitro binding characterization showed that the highest enriched motif in HOXA2 chromatin peaks is not recognized by HOXA2 in vitro, highlighting the importance of in vivo context for HOX binding specificity.\",\n      \"method\": \"ChIP-seq (in vivo binding), in vitro binding assay (EMSA or equivalent), protein-protein interaction assay for heterodimerization\",\n      \"journal\": \"Journal of Developmental Biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — heterodimerization shown by single method in single study; functional consequences not directly tested\",\n      \"pmids\": [\"34940502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HOXA3 transcriptionally activates USP15 expression (confirmed by ChIP, EMSA, and dual-luciferase reporter assays), and USP15 then deubiquitinates SQSTM1. This HOXA3/USP15/SQSTM1 axis suppresses autophagy (inhibiting autolysosome fusion) and promotes M2-type macrophage polarization in renal cell carcinoma through stimulation of CCL2 secretion.\",\n      \"method\": \"ChIP assay, EMSA, dual-luciferase reporter assay, Co-immunoprecipitation (USP15-SQSTM1 interaction), ubiquitination assay, immunofluorescence (LC3/LAMP2), in vivo xenograft experiment, Western blot\",\n      \"journal\": \"American Journal of Physiology Cell Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (ChIP, EMSA, luciferase, Co-IP, ubiquitination assay) in single lab establishing transcriptional and post-translational mechanism\",\n      \"pmids\": [\"39740793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HOXA3 regulates the differentiation, proliferation, and migration of third pharyngeal pouch endoderm (3PPE) derived from hESCs, and controls 3PPE commitment through the Wnt signaling pathway by transcriptionally activating EPHB2.\",\n      \"method\": \"hESC differentiation, HOXA3 knockdown, gene expression analysis, Wnt pathway reporter/assay, cell proliferation and migration assays\",\n      \"journal\": \"Frontiers in Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional knockdown with defined molecular pathway (EPHB2/Wnt), in vitro hESC model, single lab\",\n      \"pmids\": [\"38259452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Short WT1 transcripts (sWT1+/-) specifically upregulate HOXA3, and overexpression of HOXA3 alone reproduces the effects of sWT1+/- in AML cells: decreased cell growth, G1 arrest, reduced CD71 expression, and cytarabine resistance, demonstrating HOXA3 as a downstream effector of isoform-specific WT1 in mediating chemotherapy resistance.\",\n      \"method\": \"RNA-seq differential expression, HOXA3 overexpression, flow cytometry (cell cycle, CD71), cytarabine resistance assay\",\n      \"journal\": \"British Journal of Haematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — overexpression rescue experiment establishing HOXA3 as downstream effector, molecular pathway placement, single lab\",\n      \"pmids\": [\"38867543\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HOXA3 is a homeodomain transcription factor that acts through direct DNA binding (at Hox/Pbx bipartite sites and target gene promoters) to control cell fate decisions in pharyngeal organ development (thymus, parathyroid, carotid body) by regulating Pax1, Gcm2, and Foxn1 expression in third pharyngeal pouch endoderm and neural crest cells; it additionally functions as an apical regulator of the endothelial-to-hematopoietic transition by suppressing Runx1 and inducing Jag1-mediated Notch cis-inhibition, promotes wound healing and angiogenesis by inducing MMP-14 and uPAR expression in a uPAR-dependent manner, modulates macrophage M1/M2 polarization via Pu.1/Spi1, Stat6, and NF-κB pathways, transcriptionally activates USP15 (leading to SQSTM1 deubiquitination and autophagy suppression), and its own translation is controlled by a 5'UTR uORF-based Translation Inhibitory Element (TIE) requiring eIF2D, while early hindbrain expression is initiated by kreisler/Krml1 binding and maintained by auto/cross-regulatory Hox/Pbx feedback loops.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HOXA3 is a homeodomain transcription factor that controls cell-fate decisions during pharyngeal organ development and hematovascular differentiation by directly regulating downstream target genes [#0, #12, #24]. In the third pharyngeal pouch it acts cell-autonomously in endoderm to initiate the thymus program and to drive parathyroid differentiation, and non-cell-autonomously in neural crest cells for organ morphogenesis, with combined loss in both lineages reproducing the null athymic phenotype [#15, #17]; mechanistically it maintains Pax1 expression and operates in a Hoxa3–Pax1 genetic pathway governing epithelial proliferation, survival, and differentiation marked by Gcm2 and Foxn1 [#0, #3, #5], and is required for carotid body formation through maintenance of the third arch artery [#6]. Its early hindbrain expression in rhombomeres 5/6 is initiated by direct binding of the Maf factor Krml1 (kreisler) to a single high-affinity enhancer site and subsequently maintained through auto- and cross-regulatory Hox/Pbx feedback loops [#2, #4]. HOXA3 is an apical regulator of the endothelial-to-hematopoietic transition, restraining hematopoietic commitment by downregulating Runx1 and other key hematopoietic transcription factors and by inducing Jagged1-mediated cis-inhibition of Notch signaling [#12, #18]. In wound healing it promotes endothelial migration and angiogenesis through uPAR-dependent induction of MMP-14 and uPAR, mobilizes endothelial progenitor cells, and steers myeloid cells toward proangiogenic, M2-polarized states via Pu.1/Spi1, Stat6, Runx1, and NF-\\u03baB modulation [#9, #11, #13, #16, #19]. HOXA3 additionally functions as a direct transcriptional regulator in disease contexts, activating USP15 to suppress autophagy via SQSTM1 deubiquitination [#24] and repressing NLRP3 and HO-1 to modulate inflammasome and interferon responses [#20, #21]. Its own expression is post-transcriptionally constrained by a 5'UTR uORF-based Translation Inhibitory Element that requires the non-canonical factor eIF2D for cap-dependent inhibition [#22].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that Hoxa3 acts in dosage-dependent synergy with Hoxd3 to control axial skeletal precursor cell behavior rather than acting alone in simple positional identity.\",\n      \"evidence\": \"Genetic epistasis with Hoxa3/Hoxd3 double knockout mice and skeletal analysis\",\n      \"pmids\": [\"7913519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target genes mediating the proliferation effect not identified\", \"Direct DNA-binding evidence absent\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Defined the core developmental phenotype, showing Hoxa3 loss causes athymia and thyroid hypoplasia through effects on differentiation, not neural crest migration, and maintains Pax1 in third-pouch neural crest.\",\n      \"evidence\": \"Knockout mouse with carbocyanine dye tracing, molecular markers, and in situ hybridization\",\n      \"pmids\": [\"7635047\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Pax1 regulation is direct not established\", \"Cell-autonomy not yet resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified the upstream initiator of Hoxa3 hindbrain expression, showing Krml1/kreisler directly binds a defined enhancer to drive r5/r6 expression.\",\n      \"evidence\": \"Transgenic enhancer analysis, EMSA binding-site mapping, and kreisler mutant embryos\",\n      \"pmids\": [\"9895323\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Maintenance phase of expression not explained by this element\", \"Downstream hindbrain targets unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Resolved the Hoxa3-Pax1 pathway in thymus/parathyroid organogenesis, localizing the defect to radio-resistant epithelial stroma and linking it to epithelial death, proliferation, and Gcm2/Foxn1 marker expression.\",\n      \"evidence\": \"Compound mutant mice, fetal liver adoptive transfer, flow cytometry, and organ-specific in situ markers\",\n      \"pmids\": [\"10820253\", \"11476574\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets of Hoxa3 in epithelium not identified\", \"Mechanism of apoptosis induction unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed that sustained r5/r6 expression is maintained independently of kreisler by conserved bipartite Hox/Pbx sites mediating auto/cross-regulatory feedback.\",\n      \"evidence\": \"Transgenic mouse and chick analysis with deletion and Hox/Pbx site mutagenesis across species\",\n      \"pmids\": [\"11566863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the specific Hox/Pbx partners binding in vivo not defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Extended the developmental role to vascular structures, showing Hoxa3 is required for carotid body formation via maintenance of the third arch artery.\",\n      \"evidence\": \"Knockout mouse histology and immunohistochemistry with complete penetrance\",\n      \"pmids\": [\"12074562\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular effectors of arch artery maintenance unknown\", \"Cell type executing the requirement not pinpointed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated Hoxa3 is not only necessary but sufficient to specify somatic motoneurone identity, acting upstream of the patterning gene Irx3.\",\n      \"evidence\": \"Rhombomere transplantation and targeted gain-of-function with Irx3 in situ readout\",\n      \"pmids\": [\"12756180\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study\", \"Whether Irx3 repression is direct not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Localized the parathyroid requirement cell-autonomously to pouch endoderm, separating it from neural crest migration.\",\n      \"evidence\": \"Knockout mouse with SP-1/chromogranin A immunohistochemistry and connexin43-lacZ crest tracing\",\n      \"pmids\": [\"15100241\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Endoderm-intrinsic target genes not identified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified an angiogenic effector function, showing HOXA3 drives endothelial and keratinocyte migration and wound angiogenesis via uPAR-dependent induction of MMP-14 and uPAR.\",\n      \"evidence\": \"In vitro migration assays, in vivo gene transfer into diabetic wounds, and uPAR blocking\",\n      \"pmids\": [\"15914537\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MMP-14/uPAR are direct transcriptional targets not shown\", \"Connection to developmental role unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed HOXA3 reshapes the wound cellular environment by recruiting endothelial progenitors and suppressing pro-inflammatory NF-\\u03baB pathway members.\",\n      \"evidence\": \"GFP bone marrow chimeras, in vivo gene transfer, flow cytometry, and microarray\",\n      \"pmids\": [\"19544454\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Directness of MyD88/TOLLIP repression untested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established HOXA3 as an apical regulator of the endothelial-to-hematopoietic transition by repressing Runx1 and other hematopoietic factors, and showed it promotes proangiogenic myeloid differentiation that rescues the diabetic phenotype.\",\n      \"evidence\": \"Reciprocal loss/gain-of-function with epistasis, expression profiling, and ex vivo/in vivo functional rescue\",\n      \"pmids\": [\"21170035\", \"20974673\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Runx1 repression is direct binding not shown in this work\", \"Mechanism of myeloid reprogramming undefined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Mapped functional divergence between orthologs to the protein C-terminal domain, indicating tissue-specific activity resides outside the homeodomain.\",\n      \"evidence\": \"Knock-in of zebrafish hoxa3a at the mouse locus and chimeric protein allele with tissue rescue analysis\",\n      \"pmids\": [\"20498049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical basis of C-terminal specificity unknown\", \"Cofactor differences not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Dissected cell-autonomous versus non-autonomous roles, showing endoderm-intrinsic function in thymus/parathyroid and crest-based morphogenetic function, with combined deletion phenocopying the null.\",\n      \"evidence\": \"Tissue-specific and double conditional knockouts with Hoxa3-Cre lineage tracing\",\n      \"pmids\": [\"25249461\", \"27178667\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Lineage-specific direct targets not enumerated\", \"Temporal target switching unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed HOXA3 controls macrophage polarization, suppressing M1 and promoting M2 states via Pu.1/Spi1 and Stat6 in a DNA-binding-independent manner.\",\n      \"evidence\": \"Protein transduction in vitro, in vivo gene transfer, Western blot, and immunofluorescence of polarization markers\",\n      \"pmids\": [\"27342843\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Non-DNA-binding mechanism not molecularly defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined the HoxA3-Notch link, showing it induces Jagged1 to cis-inhibit Notch and render hemogenic endothelium non-responsive, a prerequisite step preceding EHT.\",\n      \"evidence\": \"Gain-of-function with Notch activation/inhibition, Jag1 knockdown, and expression/phenotype assays\",\n      \"pmids\": [\"29073173\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Jag1 is a direct transcriptional target not confirmed\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected HOXA3 to inflammatory and chromatin regulation, rescuing diabetic human macrophage defects through Runx1 upregulation and modulation of NF-\\u03baB and TNF promoter acetylation.\",\n      \"evidence\": \"Protein transduction, Western blot, HAT/HDAC activity assay, and ChIP of TNF promoter acetylation in primary human cells\",\n      \"pmids\": [\"31626638\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect Runx1 regulation unresolved (contrasts with hematopoietic repression)\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placed HOXA3 in a GDF11/Smad2/3 axis as a direct transcriptional repressor of NLRP3 that limits cardiomyocyte pyroptosis.\",\n      \"evidence\": \"ChIP assay, AAV9 in vivo overexpression, and Smad pathway Western blot\",\n      \"pmids\": [\"33100331\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generalizability beyond cardiomyocytes unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified an antiviral-suppressive role in which HOXA3 represses HO-1 transcription, weakening HO-1-IRF3 interaction and dampening type I interferon production.\",\n      \"evidence\": \"Luciferase reporter, knockdown/overexpression, Co-IP, and IRF3 phosphorylation/translocation assays during PRRSV infection\",\n      \"pmids\": [\"34851144\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct HOXA3 binding to HO-1 promoter via ChIP not shown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Revealed translational control of HOXA3 itself through a 5'UTR uORF-based Translation Inhibitory Element requiring eIF2D, with an IRES enabling cap-independent translation.\",\n      \"evidence\": \"In vitro translation, uORF mutagenesis, eIF2D requirement, and reporter assays\",\n      \"pmids\": [\"34076576\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts engaging the TIE versus IRES unknown\", \"In vivo relevance not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Reported that HOXA2 and HOXA3 can heterodimerize, raising the possibility of combinatorial control of HOX binding specificity.\",\n      \"evidence\": \"ChIP-seq, in vitro binding assays, and protein-protein interaction assay\",\n      \"pmids\": [\"34940502\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Functional consequences of heterodimerization not directly tested\", \"Single method for the interaction\", \"In vivo relevance unverified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established a HOXA3/USP15/SQSTM1 axis in which HOXA3 directly activates USP15 to suppress autophagy and promote M2 polarization and tumor growth in renal cell carcinoma.\",\n      \"evidence\": \"ChIP, EMSA, dual-luciferase, Co-IP, ubiquitination assay, autophagy imaging, and xenograft\",\n      \"pmids\": [\"39740793\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality across tumor types untested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended the developmental role to a human model, showing HOXA3 controls third pharyngeal pouch endoderm commitment via Wnt signaling through transcriptional activation of EPHB2.\",\n      \"evidence\": \"hESC differentiation with HOXA3 knockdown, Wnt reporter, and proliferation/migration assays\",\n      \"pmids\": [\"38259452\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct EPHB2 binding not fully resolved\", \"In vivo human relevance not established\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Positioned HOXA3 as a downstream effector of isoform-specific WT1, mediating G1 arrest and cytarabine resistance in AML.\",\n      \"evidence\": \"RNA-seq, HOXA3 overexpression, cell-cycle/CD71 flow cytometry, and chemoresistance assays\",\n      \"pmids\": [\"38867543\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"HOXA3 transcriptional targets driving resistance not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The unifying biochemical question — what cofactors and direct genome-wide target sets allow one homeodomain factor to switch between developmental patterning, hematovascular fate, and inflammatory/tumor programs — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No comprehensive genome-wide HOXA3 binding map across cell types\", \"C-terminal specificity determinants not mechanistically explained\", \"Reconciliation of context-dependent Runx1 repression versus activation unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [12, 20, 24, 25]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 4, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [24]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 5, 6, 15, 17, 25]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 4, 12, 24]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [16, 19, 20, 24]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"HOXA2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":6,"faith_total":7,"faith_pct":85.71428571428571}}